Preferred Label : Gadopiclenol;
NCIt synonyms : Gadolinium-based Magnetic Resonance Contrast Agent P03277; GBCA P03277; WHO 10744; (alpha3,alpha6,alpha9-Tris(3-((2,3-dihydroxypropyl)amino)-3-oxopropyl)-3,6,9,15-tetraazabicyclo(9.3.1)pentadeca-1(15),11,13-triene-3,6,9-triacetato(3-)-kappaN3,kappaN6,kappaN9,kappaN15,kappaO3,kappaO6,kappaO9)gadolinium;
NCIt definition : A gadolinium-based paramagnetic contrast agent, with potential imaging enhancing activity
upon magnetic resonance imaging (MRI). Upon administration of gadopiclenol and placement
in a magnetic field, this agent produces a large magnetic moment and creates a large
local magnetic field, which can enhance the relaxation rate of nearby protons. This
change in proton relaxation dynamics, increases the MRI signal intensity of tissues
in which this agent has accumulated; therefore, contrast and visualization of those
tissues is enhanced compared to unenhanced MRI.;
UNII : S276568KOY;
InChIKey : GNRQMLROZPOLDG-UHFFFAOYSA-K;
CAS number : 933983-75-6;
Drug name : Elucirem;
Molecule name : P03277; P 03277;
NCI Metathesaurus CUI : CL509066;
Origin ID : C128640;
UMLS CUI : C5392287;
Currated CISMeF NLP mapping
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
- concept_is_in_subset
